Docket #: S25-302
Therapeutic Approach for Benign Uterine Conditions
Stanford researchers have identified a therapeutic approach for benign uterine conditions. The approach targets the endometrium directly rather than the hormonal environment that sustains them.
Evidence supporting this concept has been established in human endometrial cell models and in animal models.
Stage of Development
Preclinical
Applications
- Therapeutic for benign uterine conditions
- Alternative for patients who cannot tolerate or do not respond to standard of care
Advantages
- Mechanism distinct from current standard of care
- Preclinical proof of concept in human cell models and an animal model
Related Links
Similar Technologies
-
Implant for improved treatment of early stage osteonecrosis of the hip S15-027Implant for improved treatment of early stage osteonecrosis of the hip
-
Repurposing Metformin to Prevent Corticosteroid-Induced Osteonecrosis S24-375Repurposing Metformin to Prevent Corticosteroid-Induced Osteonecrosis
-
Collagen-Based Hydrogels for Cell and Growth Factor Delivery S19-552Collagen-Based Hydrogels for Cell and Growth Factor Delivery